This is a Validated Antibody Database (VAD) review about rhesus mac.. CD4, based on 78 published articles (read how Labome selects the articles), using CD4 antibody in all methods. It is aimed to help Labome visitors find the most suited CD4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
others
  • flow cytometry; human; loading ...; fig e1a, 3h
 CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig e1a, 3h). Nature (2019) ncbi
  • flow cytometry; human; loading ...; fig 7c, 7f
 CD4 antibody (Biolegend, clone OKT4) was used in flow cytometry on human samples (fig 7c, 7f). Sci Rep (2019) ncbi
BioLegend
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 1b
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 1b). Front Immunol (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...
BioLegend CD4 antibody (Biolegend, 317441) was used in flow cytometry on human samples . Cell Rep Med (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; loading ...; fig 2h
BioLegend CD4 antibody (Biolegend, 317418) was used in flow cytometry on human samples at 1:100 (fig 2h). Nat Med (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; mouse; 1:1000; loading ...; fig 7l
BioLegend CD4 antibody (Biolegend, 317415) was used in flow cytometry on mouse samples at 1:1000 (fig 7l). Cell Rep Med (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:50; loading ...
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples at 1:50. Nature (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Arthritis Res Ther (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Aging Cell (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:200
BioLegend CD4 antibody (Biolegend, 317414) was used in flow cytometry on human samples at 1:200. Science (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:20; fig 5a
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples at 1:20 (fig 5a). Science (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD4 antibody (BioLegend, 317440) was used in flow cytometry on human samples (fig 3b). Cell (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; loading ...; fig 1s3a
BioLegend CD4 antibody (Biolegend, 317416) was used in flow cytometry on human samples at 1:100 (fig 1s3a). elife (2020) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig s1a). Sci Adv (2020) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s12a
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig s12a). Nat Commun (2020) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD4 antibody (Biolegend, 317442) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig e1a, 3h
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig e1a, 3h). Nature (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 7c, 7f
BioLegend CD4 antibody (Biolegend, clone OKT4) was used in flow cytometry on human samples (fig 7c, 7f). Sci Rep (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (Biolegend, 317440) was used in flow cytometry on human samples (fig 1a). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; loading ...; fig 2s1b
BioLegend CD4 antibody (Biolegend, 317444) was used in flow cytometry on human samples at 1:100 (fig 2s1b). elife (2019) ncbi
mouse monoclonal (OKT4)
  • immunocytochemistry; rat; 1:400; loading ...; fig 4a
BioLegend CD4 antibody (BioLegend, 317402) was used in immunocytochemistry on rat samples at 1:400 (fig 4a). elife (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s8
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig s8). Nat Commun (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1s2
BioLegend CD4 antibody (BioLegend, 317434) was used in flow cytometry on human samples (fig 1s2). elife (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 7j
BioLegend CD4 antibody (BioLegend, 317434) was used in flow cytometry on human samples (fig 7j). Cell (2019) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (Biolegend, OKT4) was used . J Biol Chem (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s1f
BioLegend CD4 antibody (Biolegend, 317434) was used in flow cytometry on human samples (fig s1f). Cell (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s3c
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig s3c). Transl Oncol (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; loading ...; fig 1c
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig 1c). J Virol (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1e
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 1e). J Immunol (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 1a). Bone Marrow Transplant (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD4 antibody (Biolegend, 317407) was used in flow cytometry on human samples (fig 3b). Biosci Rep (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD4 antibody (BioLegend, OKT-4) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig s2). Nat Immunol (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 1a). Int J Infect Dis (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 2d
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 2d). J Exp Med (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; fig 1a
BioLegend CD4 antibody (BioLegend, 317408) was used in flow cytometry on human samples at 1:100 (fig 1a). Nat Commun (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig s2e
BioLegend CD4 antibody (BioLegend, 317408) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 5c
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 5c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 4b). J Clin Invest (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 6a). Oncoimmunology (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend CD4 antibody (BioLegend, 317441) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; loading ...; fig s4e
In order to study CXCR5+ CD8 T cells in SIV-infected animals, BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig s4e). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 3c). J Virol (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:25; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples at 1:25 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 4s1b
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 4s1b). PLoS ONE (2016) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (BioLegend, 317416) was used . Stem Cell Reports (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 6f
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 6f). Sci Rep (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig s4a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig s4a). J Immunol (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; loading ...; fig 1h
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CD4 antibody (BioLegend, 317433) was used in flow cytometry on rhesus macaque samples (fig 1h). Nat Med (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; loading ...; fig 8a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig 8a). PLoS ONE (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 5a
In order to characterize B and T cells from patients with thrombocytopenia, BioLegend CD4 antibody (BioLegend, 317429) was used in flow cytometry on human samples (fig 5a). Haematologica (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 1
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
In order to describe a method to expand antigen-specific regulatory T cells in vivo, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Nature (2016) ncbi
mouse monoclonal (OKT4)
  • immunohistochemistry - frozen section; rhesus macaque
BioLegend CD4 antibody (Biolegend, 317422) was used in immunohistochemistry - frozen section on rhesus macaque samples . Mucosal Immunol (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; fig 3
In order to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig 3). J Virol (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; mouse
In order to study immune escape from CD8+ T cell killing mediated by PD-L1 expression on retrovirus-infected cells, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on mouse samples . PLoS Pathog (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 1
In order to assess the CD4/CD8 ratio as a marker for CD4+ T cell dysfunction in chronic HIV infection, BioLegend CD4 antibody (Biolegend, Clone OKT4) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
In order to study the relationship between HIV infection and the innate immune system, BioLegend CD4 antibody (Biolegend, 317427) was used in flow cytometry on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 2
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:200; fig 1
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples at 1:200 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; fig 4
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig 4). J Virol (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 6
In order to report the phase I trial results of CDX-301, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 6). Bone Marrow Transplant (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, 317427) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 4b). J Immunol Res (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, 317435) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (Biolegend, 317428) was used . Cancer Res (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque
In order to examine the effect of HMBPP-deficient Listeria mutant immunization, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (Biolegend, OKT4) was used . PLoS ONE (2014) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (Biolegend, 317417) was used . J Vis Exp (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (BioLegend, 317416) was used . J Immunol (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD4 antibody (Biolegend, OKT-4) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples . Tuberculosis (Edinb) (2013) ncbi
Articles Reviewed
  1. Ming S, Yin H, Li X, Gong S, Zhang G, Wu Y. GITR Promotes the Polarization of TFH-Like Cells in Helicobacter pylori-Positive Gastritis. Front Immunol. 2021;12:736269 pubmed publisher
  2. Fierle J, Brioschi M, de Tiani M, Wetterwald L, Atsaves V, Abram Saliba J, et al. Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1. Cell Rep Med. 2021;2:100362 pubmed publisher
  3. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  4. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  5. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed publisher
  6. Hawerkamp H, Domdey A, Radau L, Sewerin P, Oláh P, Homey B, et al. Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation. Arthritis Res Ther. 2021;23:144 pubmed publisher
  7. Martínez Zamudio R, Dewald H, Vasilopoulos T, Gittens Williams L, Fitzgerald Bocarsly P, Herbig U. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell. 2021;20:e13344 pubmed publisher
  8. Wang Q, Gao H, Clark K, Mugisha C, Davis K, Tang J, et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science. 2021;371: pubmed publisher
  9. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  10. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  11. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed publisher
  12. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  13. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  14. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  15. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  16. Muhammad F, Wang D, Montieth A, Lee S, Preble J, Foster C, et al. PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease. Sci Rep. 2019;9:16941 pubmed publisher
  17. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  18. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
  19. Fletcher Jones A, Hildick K, Evans A, Nakamura Y, Wilkinson K, Henley J. The C-terminal helix 9 motif in rat cannabinoid receptor type 1 regulates axonal trafficking and surface expression. elife. 2019;8: pubmed publisher
  20. Thauland T, Pellerin L, Ohgami R, Bacchetta R, Butte M. Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome. Front Immunol. 2019;10:753 pubmed publisher
  21. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher
  22. Naamati A, Williamson J, Greenwood E, Marelli S, Lehner P, Matheson N. Functional proteomic atlas of HIV infection in primary human CD4+ T cells. elife. 2019;8: pubmed publisher
  23. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed publisher
  24. Sueyoshi K, Ledderose C, Shen Y, Lee A, Shapiro N, Junger W. Lipopolysaccharide suppresses T cells by generating extracellular ATP that impairs their mitochondrial function via P2Y11 receptors. J Biol Chem. 2019;294:6283-6293 pubmed publisher
  25. Li H, van der Leun A, Yofe I, Lubling Y, Gelbard Solodkin D, van Akkooi A, et al. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma. Cell. 2019;176:775-789.e18 pubmed publisher
  26. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed publisher
  27. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed publisher
  28. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  29. Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, et al. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;: pubmed publisher
  30. Zhao S, Ding J, Wang S, Li C, Guo P, Zhang M, et al. Decreased expression of circulating Aire and increased Tfh/Tfr cells in myasthenia gravis patients. Biosci Rep. 2018;38: pubmed publisher
  31. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed publisher
  32. Clayton K, Collins D, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018;19:475-486 pubmed publisher
  33. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  34. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  35. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed publisher
  36. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  37. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  38. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  39. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  40. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  41. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  42. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  43. Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, et al. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. J Virol. 2017;91: pubmed publisher
  44. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  45. Puerta Arias J, Pino Tamayo P, Arango J, Gonzalez A. Depletion of Neutrophils Promotes the Resolution of Pulmonary Inflammation and Fibrosis in Mice Infected with Paracoccidioides brasiliensis. PLoS ONE. 2016;11:e0163985 pubmed publisher
  46. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed publisher
  47. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed publisher
  48. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  49. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  50. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
  51. Zurawski G, Zurawski S, Flamar A, Richert L, Wagner R, Tomaras G, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS ONE. 2016;11:e0153484 pubmed publisher
  52. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  53. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  54. Clemente Casares X, Blanco J, Ambalavanan P, Yamanouchi J, Singha S, Fandos C, et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature. 2016;530:434-40 pubmed publisher
  55. Veazey R, Pilch Cooper H, Hope T, Alter G, Carias A, Sips M, et al. Prevention of SHIV transmission by topical IFN-β treatment. Mucosal Immunol. 2016;9:1528-1536 pubmed publisher
  56. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed publisher
  57. Akhmetzyanova I, Drabczyk M, Neff C, Gibbert K, Dietze K, Werner T, et al. PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing. PLoS Pathog. 2015;11:e1005224 pubmed publisher
  58. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed publisher
  59. Bego M, Côté Ã, Cohen Ã. Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System. J Vis Exp. 2015;: pubmed publisher
  60. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  61. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  62. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  63. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed publisher
  64. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  65. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed publisher
  66. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  67. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed publisher
  68. Crompton J, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil R, et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 2015;75:296-305 pubmed publisher
  69. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  70. Frencher J, Shen H, Yan L, Wilson J, Freitag N, Rizzo A, et al. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vγ2Vδ2 T cells. J Leukoc Biol. 2014;96:957-67 pubmed publisher
  71. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed publisher
  72. Chung Y, Kim E, Abdel Wahab O. Femoral bone marrow aspiration in live mice. J Vis Exp. 2014;: pubmed publisher
  73. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  74. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed publisher
  75. Uhlenbrock F, Hagemann Jensen M, Kehlet S, Andresen L, Pastorekova S, Skov S. The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway. J Immunol. 2014;193:1654-65 pubmed publisher
  76. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  77. Cartwright E, McGary C, Cervasi B, Micci L, Lawson B, Elliott S, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol. 2014;192:4666-73 pubmed publisher
  78. Marin N, Paris S, Rojas M, Garcia L. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB. Tuberculosis (Edinb). 2013;93:155-66 pubmed publisher